Annexon, Inc. (NASDAQ:ANNX) on Tuesday presented data for its late-stage targeted therapy, tanruprubart (formerly ANX005), ...

CoStar’s $2.8 billion bid for Domain is not expected to be impacted by a review of major investments by the US property giant ...